BELLUS Health Inc.
BLU was delisted on the 28th of June, 2023.
106 hedge funds and large institutions have $828M invested in BELLUS Health Inc. in 2023 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 23 closing their positions.
19% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 32
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
11% less capital invested
Capital invested by funds: $935M → $828M (-$106M)
13% less funds holding
Funds holding: 122 → 106 (-16)
61% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 23
77% less call options, than puts
Call options by funds: $158K | Put options by funds: $682K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCM
Laurion Capital Management
New York
|
+$25.5M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$17.1M |
| 3 |
Millennium Management
New York
|
+$11.6M |
| 4 |
CC
Commodore Capital
New York
|
+$9.9M |
| 5 |
ABG
Ally Bridge Group
New York
|
+$8.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$30.5M |
| 2 |
AG
Artal Group
Luxembourg
|
-$30.4M |
| 3 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$5.49M |
| 4 |
Goldman Sachs
New York
|
-$5.16M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$3.11M |
BLU Hedge Fund Activity: Q1 2023 in Review
106 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in BELLUS Health Inc. (BLU) for Q1 2023, worth a combined $828M — down 11% from $935M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of BLU and 9 opened new positions — a net loss of 14 holders — while 32 trimmed existing stakes and 38 added.
The largest buyer was Laurion Capital Management, adding an estimated $25.5M. The largest seller was Perceptive Advisors, cutting an estimated $30.5M.
- 106 institutional investors held BELLUS Health Inc. (BLU) as of Q1 2023, down from 122 in Q4 2022.
- Funds reported $828M of BELLUS Health Inc. stock for Q1 2023, down 11% quarter-over-quarter.
- 9 funds opened new BELLUS Health Inc. positions in Q1 2023 and 23 closed out, a net change of -14 holders.
- The largest BELLUS Health Inc. buyer in Q1 2023 was Laurion Capital Management, an estimated $25.5M added.
- The largest BELLUS Health Inc. seller in Q1 2023 was Perceptive Advisors, an estimated $30.5M sold.
Based on aggregated 13F filings for Q1 2023.